Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ablynx

Explore full profile

Proprietary therapeutic proteins for treating life-threatening diseases

Ghent, BelgiumFounded 2001Biotech & Life Sciences
Valuation $4.80B Market cap · 2026
Revenue $135M Latest reported FY
EBITDA $88M Latest reported FY

At a glance

Founded
2001
Headquarters
Ghent, Belgium
Listing
IPO 2007
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later8 investors entered at this stage

  • Flanders Institute for Biotechnology
  • Alta Partners
  • KBC
  • KBC
  • Vrije Universiteit Brussel
  • SR One
  • Alta Ventures
  • Abingworth

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 6 startups shown

Former Ablynx employees who went on to found companies, sorted by Dealroom signal score.

argenxEst. 2008
Tim Van HauwermeirenBelgium
Signal score93
Confo TherapeuticsEst. 2015
Jan SteyaertBelgium
Signal score78
Ona TherapeuticsEst. 2019
VVValerie VanhoorenSpain
Signal score75
Curve TherapeuticsEst. 2019
SKSimon KerryUnited Kingdom
Signal score71
ComplixEst. 2008
Mark VaeckBelgium
Signal score65
1 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇧🇪 Belgium97.5%
🇺🇸 United States1.2%
🇳🇱 Netherlands1.2%
3 countries shown
Web traffic by country
180 monthly visits
across markets
🇫🇷 France111.1%
Top 1 markets shown

Patents

Estimated portfolio value
$5.8B

3,641 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ablynx on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ablynx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles